Drugs Health Pharma

Pfizer enters Hong Kong migraine market, its first in Asia

HQ Team September 29, 2023: Pfizer announced the availability of its migraine management drug Rimegepant in Hong Kong — the company’s first market.

Read More
Drugs Health Pharma

CDC, ECDC differ on vaccination program for fall-winter season

HQ Team September 13, 2023: The US national public agency has recommended a COVID-19 vaccination policy where updated shots are given starting from.

Read More
Drugs Health Pharma

USFDA green lights vaccines to fight COVID-19 variants in flu season

HQ Team September 12, 2023: The US drug and medicine regulator, the FDA, approved COVID-19 vaccines made by Moderna Inc., Pfizer Inc., and  BioNTech.

Read More
Drugs Health Pharma

Pfizer gets FDA nod for infant respiratory tract infection vaccine

HQ Team August 22, 2023: Pfizer Inc’s Abrysvo, a vaccine used in pregnant women to prevent lower respiratory tract infection caused by respiratory.

Read More
Drugs Health Pharma

US regulator approves Pfizer’s Elrexfio to treat multiple myeloma

HQ Team August 15, 2023: The USFDA has granted accelerated approval for Pfizer Inc’s Elrexfio to treat incurable blood cancer, multiple myeloma, that.

Read More
Drugs Health Pharma

Alexion, Pfizer sign $1 billion accord for genomic medicines

HQ Team July 29, 2023: Alexion, AstraZeneca Rare Disease, an arm of AstraZeneca group, has signed a $1 billion pact with Pfizer for.

Read More
Drugs Health Pharma

Britain’s GSK gets EMA clearance for drug to prevent HIV 

HQ Team July 24, 2023: British pharmaceutical firm, GSK Plc., has got marketing authorization from the European Medicines Authority for its injectable, and.

Read More
Drugs Health Pharma

Samsung Biologics inks $879 million deal with Pfizer to make drugs

HQ Team July 4, 2023: Samsung Biologics Co., the biotech arm of South Korea’s Samsung Group, has inked two deals worth $897 million.

Read More
Drugs Health Pharma

Pfizer gets FDA nod for combination drug to treat advanced prostate cancer

HQ Team June 21, 2023: The USFDA has approved Pfizer Inc’s oral Talzenna drug in combination with Xtandi to treat advanced prostate cancer.

Read More
Drugs Health Pharma

Pfizer warns of penicillin shortage as syphilis rates rise in United States

HQ Team June 14, 2023: Pfizer Inc. announced a shortage of several doses of penicillin to treat strep throat and other infections in.

Read More
X